The gene known as APOE2 shows signs of protecting brain cells as we age by boosting DNA repair and slowing cellular aging, a finding surfaced by lab work on human neurons and supported in mice; researchers see fresh directions for therapies but warn this is a biological insight, not a treatment, and recommend standard brain-healthy habits for now.
The APOE gene, short for apolipoprotein E, helps move fats and cholesterol around the body and is especially important in the brain. Different versions of this gene change risk: APOE4 raises the chance of Alzheimer’s disease, while APOE2 has long been linked to lower risk and even exceptional longevity. That contrast pushed scientists to ask what APOE2 does inside neurons that APOE4 does not.
Researchers at the Buck Institute used human brain cells made from stem cells to dig into that question. They discovered that neurons carrying APOE2 were better at repairing DNA damage and more resistant to cellular senescence, the process where cells age and stop working properly. Cells with APOE4 looked frailer and showed more signs of dysfunction in the same experiments.
“We found that APOE2, a gene linked to exceptional longevity (enriched in centenarians), helps human neurons better repair DNA damage and resist becoming senescent, or aged and dysfunctional,” senior author Lisa M. Ellerby, PhD, professor at the Buck Institute, said. The team said they were “very surprised” to find the protective mechanism centered on DNA signaling and repair rather than only on cholesterol handling. “APOE2 is so well-known for cholesterol transport that uncovering this major pathway, and seeing it hold up across multiple human neuron models and aged mice, was striking for us,” Ellerby added.
The lab results did not stand alone: similar patterns showed up in follow-up mouse studies, strengthening the link between APOE2 and neuronal resilience. The researchers also tested adding APOE2 protein directly to neurons with APOE4 and saw reduced DNA damage after radiation stress, hinting at possible ways to mimic APOE2’s effect. Those experiments suggest interventions could aim to simulate APOE2’s protective behavior or otherwise boost the brain’s DNA repair machinery.
Outside experts called the work meaningful. Christopher Weber, PhD, senior director of global scientific initiatives at the Alzheimer’s Association, described it as an “exciting and significant study.” “It shifts attention beyond APOE’s well-known role in cholesterol transport toward a new function — shaping how brain cells maintain their integrity as they age — and opens up some new directions for therapy development, particularly for people who carry the higher-risk APOE4 variant,” he said, noting the potential therapeutic implications.
The Alzheimer’s Association already has active projects investigating APOE2’s protective role, and other groups are funding complementary work. Caghan Kizil, PhD, an associate professor of neurological sciences at Columbia, said, “This study goes beyond the long-known observation that APOE2 is linked to longevity and a lower risk of Alzheimer’s disease and aims to explain why this protection may happen.” That perspective could help explain why some brains keep working well into old age while others do not.
“What I find especially interesting is the idea that Alzheimer’s may partly reflect the brain losing its ability to stay resilient with age,” Kizil said. Growing evidence suggests APOE-related risk is not just about amyloid buildup, but also about how aging, inflammation, blood vessel health and internal repair systems interact over years. Understanding that interaction could steer research toward keeping vulnerable brains resilient rather than simply chasing single pathological markers.
The authors were careful to note limits: the findings describe a biological mechanism seen in cells and mice, not a clinical treatment. “Our laboratory study in human iPSC-derived neurons and mice describes a biological mechanism and not a clinical treatment,” Ellerby said, warning that the precise molecular details still need work. She also cautioned against using this single study to change medical choices or to justify genetic testing for longevity.
“The results are complex and difficult,” Ellerby noted, and the team recommended sensible, proven steps to support brain health. Regular exercise, good sleep, attention to cardiovascular health and avoiding genotoxic exposures like smoking help protect DNA and slow cellular aging. “These are all super beneficial to your health, regardless of your APOE variant,” the researcher added.
